Business Wire
-
Monarch Diagnostics Launches New Clinical Lab In Dallas, Expanding Services To Texas
10/29/2025
Monarch Diagnostics today announced the opening of its newest full-service clinical laboratory in Dallas, Texas.
-
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership In Automated Sample Processing
10/28/2025
QIAGEN today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.
-
Seek Labs Expands Global Disease Atlas With Mapping Of Hemorrhagic Fever Viruses Through BioSeeker
10/21/2025
Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease Atlas to include multiple hemorrhagic fever viruses.
-
GeneDx Granted FDA Breakthrough Device Designation For Its ExomeDx And GenomeDx Testing
10/20/2025
GeneDx a leader in delivering improved health outcomes through genomic insights, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its whole genome and exome tests associated with causes of life-threatening diseases or genetic disorders to aid in diagnosis of symptomatic patients.
-
Augurex Announces Expansion Of Availability Of The JOINTstat Diagnostic Test For Rheumatoid Arthritis With MitogenDx
10/15/2025
Augurex Life Sciences Corp., a leader in autoimmune-based diagnostics, today announced an agreement with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology diagnostic testing.
-
Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging The Gap Between PCR And Next-Generation Sequencing Technologies
10/7/2025
Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a new benchmark for sensitivity in genomics, announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing.
-
Revvity Announces Program To Revolutionize The Early Detection Of Type 1 Diabetes
10/2/2025
Revvity, Inc. today announced a program for expansion of its type 1 diabetes (T1D) offering to include a population-scale assay for early detection with support from Sanofi.
-
Quantabio Advances Newborn Screening And Emerging Applications By Streamlining DNA Extraction From Dried Blood Spot Samples
9/30/2025
Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the launch of the sparQ Lysis Kit.
-
Thermo Fisher Scientific Showcases The Thermo Fisher Connect Platform At Lab Of The Future Europe
9/30/2025
Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company’s Thermo Fisher Connect Platform can integrate and future-proof laboratories.
-
Agilent Introduces The Altura Line Of Inert HPLC Columns For Superior Results In Biotherapeutic Testing
9/29/2025
Agilent Technologies Inc. today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biotherapeutics applications.